USRE45404E1 - Powder medicine applicator for nasal cavity - Google Patents

Powder medicine applicator for nasal cavity Download PDF

Info

Publication number
USRE45404E1
USRE45404E1 US12/576,219 US57621909A USRE45404E US RE45404 E1 USRE45404 E1 US RE45404E1 US 57621909 A US57621909 A US 57621909A US RE45404 E USRE45404 E US RE45404E
Authority
US
United States
Prior art keywords
capsule
medicine
pump
housing
detaching
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US12/576,219
Inventor
Tatsuo Tsutsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Nippon Biomedical Laboratories Ltd
Original Assignee
Shin Nippon Biomedical Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Nippon Biomedical Laboratories Ltd filed Critical Shin Nippon Biomedical Laboratories Ltd
Priority to US12/576,219 priority Critical patent/USRE45404E1/en
Application granted granted Critical
Publication of USRE45404E1 publication Critical patent/USRE45404E1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • A61M15/0038Cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • A61M15/0041Details of the piercing or cutting means with movable piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075Bulb type

Definitions

  • the present invention concerns an optimal device to deliver powdery medicine dosing into the nasal cavity.
  • a treatment method to deliver a powdery medicine into the nasal cavity of a patient suffering from asthma or nasal allergy has been known generally.
  • a powdery medicine filled in a capsule is administered into the nasal cavity using a special delivery device.
  • JP-A No. 59-34267 (hereinafter referred to as prior art) has proposed a delivery device used for the treatment.
  • the device of the prior art comprises a cylindrical member having a pump on the air inlet and a concave part in which a capsule is inserted on the air exit of the cylindrical member.
  • a top end part is fitted into the concave part to form a capsule housing part, and an air guide passage having a valve mechanism is formed from the capsule housing part to the pump.
  • Another valve mechanism is provided to the other side of the pump, and air is supplied to the capsule housing part through the air guide passage having a valve mechanism upon pressing of the pump, and external air is sucked into the pump through the another valve upon removal of the pump pressure.
  • the cylindrical member has, at its top end, a cap fitted to the top end and a needle is extended axially in the cap so as to perforate both axial ends of the capsule by engaging the cap in a state of fitting the concave part of the cylindrical member and the top end having an opening.
  • the capsule after inserting the capsule filled with a powdery medicine into the concave part of the cylindrical member, the capsule is inserted and fixed in the capsule housing portion by fitting the top end. Then a cap is fitted to the top end made of a hard resin to perforate at both axial top ends of the capsule by a needle built inside the cap and guided to the top end.
  • a user detaches the cap from the cylindrical member and inserts the top end into one of the nasal nostril and presses the pump. Then, when the pump is pressed, air from the pump flows through the air guide passage into the capsule to deliver the medicine in the capsule to the nasal cavity of the user. Further, by repeating the operations for both nasal cavities, the medicine is dosed to both of the nasal cavities.
  • the top end is fitted detachably to the cylindrical member and then a cap is detachably provided to the cylindrical member.
  • a cap is detachably provided to the cylindrical member.
  • the user upon dosing of the medicine, the user inserts the top end into the nasal nostril.
  • the top end since the top end is made of a rigid resin, it may be a worry of injuring the nasal nostril upon insertion. Further, since the top end does not smoothly fitted to the shape of the user's nostril, this hinders application of medicine to the nasal cavity making it impossible for efficient dosing.
  • the present invention intends to overcome such problems.
  • the present invention of claim 1 for solving the problems described above comprises a capsule housing/holding part for housing and holding a capsule filled with a powdery medicine, a pump installed in the capsule housing/holding part for supplying dosing air to the capsule housing/holding part, a medicine delivery part with a top end which may be optionally branched into two ways for delivering the medicine in the capsule loaded into the capsule housing/holding part from the pump to the user's nasal cavity by air supplied through an air flow passage formed in the capsule housing/holding part, a capsule setting/detaching part built drawably in the capsule housing/holding part so as to be movable in the lateral direction relative to the axial direction of the capsule for setting and detaching the capsule thereby perforating at both axial ends of the capsule, and cutting blades built laterally relative to the axial direction of the capsule in the capsule housing/holding part for perforating at both axial ends of the capsule.
  • the invention of claim 2 comprises a medicine capturing/collecting part having a specific structure of an air flow passage for capturing and collecting a powdery medicine dropping and flowing backwardly from the capsule after perforation so as not to flow the medicine backwardly and capable of dosing the thus captured and collected powdery medicine by the pump actuation, and a one-way valve the opening pressure of which is controlled by a spring.
  • the invention of claim 3 comprises the nozzle for the medicine spray part constituted with a flexible tube for insertion while conforming the shape of the user's nasal nostril for dosing when the user applies the powdery medicine to the nasal cavity.
  • a capsule is placed in the capsule setting/detaching part built drawably so as to move in the lateral direction relative the axial direction of the capsule in the capsule housing/holding part and cutting blades built laterally to the axial direction of the capsule in the capsule housing/holding part perforate at both axial ends of the capsule.
  • air is supplied from the pump upon dosing and the air flows into the perforated capsule to deliver and dose the medicine in the capsule through the medicine passage in the medicine delivery part from the nozzle to the user's nasal cavity.
  • the medicine capturing/collecting part, and the one-way valve the opening pressure of which is controlled by the spring are built in the air flow passage between the capsule housing/holding part and the pump, they capture and collect the medicine falling and flowing backwardly from the capsule to the pump upon perforation of the capsule and can prevent falling and backward flow to the pump.
  • the one-way valve is opened by the flow under pressure of air from the pump to deliver and dose the captured and collected medicine together with the medicine in the capsule by way of the capsule housing/holding part and the medicine delivery part from the nozzle to the user's nasal cavity.
  • the user inserts the nozzle of the medicine delivery part into the nasal nostril upon dosing the medicine to the nasal cavity. Since the nozzle is made of a flexible tube, it can be inserted conforming the user's nasal nostril.
  • FIG. 1 is a side elevational view illustrating an embodiment of a powdery medicine delivery device according to the present invention.
  • FIG. 2 is a cross sectional view illustrating an embodiment of a powdery medicine delivery device according to the present invention.
  • FIG. 3 is a view showing a state of drawing out a capsule setting/detaching part and placing a capsule therein in FIG. 2 .
  • FIG. 4 is a cross sectional side elevational view showing a state in which cutting blades are cutting a capsule end in the course where the capsule setting/detaching part with the capsule placed therein is inserted into a capsule housing/holding part.
  • FIG. 5 is a cross sectional view showing a state in which the capsule end is cut off by cutting blades, and the medicine in the capsule upon completion of perforation is falling and flowing backwardly to the pump in FIG. 2 .
  • FIG. 6 is a cross sectional view in a state where the medicine in the capsule is under delivery and dosing by pressing the pump.
  • FIG. 7 is a cross sectional view showing another embodiment of a powdery medicine delivery device of the invention.
  • FIG. 1 is a side elevational view of an embodiment of a device to deliver the powdery medicine into the nasal cavity according to the present invention
  • FIG. 2 is a cross sectional side elevational view of a device to deliver the powdery medicine into the nasal cavity shown in the embodiment.
  • a powdery medicine delivery device 10 for nasal cavity comprises, generally, a capsule housing/holding part 30 for housing and holding a capsule K together with a medicine delivery part 20 , a capsule setting/detaching part 40 built drawably in the capsule housing/holding part 40 and a pump 50 built in the air inlet side of the capsule housing/holding part 30 for supplying air to the capsule, and cutting blades 60 a, 60 b situated at both axial ends of the capsule K of the capsule setting/detaching part 40 of the capsule housing/holding part 30 for perforating holes at both axial ends of the capsule K by setting/detaching operation of the capsule setting/detaching part 40 .
  • a medicine passage 21 is built in an upper part (air exit side) with respect to the axial direction of the capsule K of the capsule housing/holding part 30 , and nozzles 22 A and 22 B made of flexible tubes are formed to the top end of the medicine passage 21 .
  • An air flow passage 31 of the capsule housing/holding part 30 axially below the capsule K (air inlet side) includes a medicine capturing/collecting part 32 for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule K, and a one-way valve 30 also preventing falling and backward flowing of the powdery medicine from the capsule K to the pump 50 .
  • the one-way valve 33 is adapted to prevent back flow of air such that it opens when the pressure of air from the pump 50 reaches at or higher than a prescribed pressure and closes the air flow inlet 35 when the pressure of air from the pump 50 is lower than the prescribed pressure.
  • the capsule setting/detaching part 40 has a capsule attaching/detaching recess 41 at a position of attaching or detaching the capsule K, such that it can be set and detached drawably in the lateral direction with respect to the axial direction of the capsule K to the capsule housing/holding part 30 and a drawing end 44 of the capsule setting/detaching part 40 is regulated by the abutment of the detaching end 44 to the protrusion 37 built in the capsule housing/holding part 30 .
  • the inlet end is regulated by the abutment of a setting/detaching protrusion 45 of the capsule setting/detaching part 40 against the abutment face 36 of the capsule housing/holding part 30 .
  • the pump 50 is comprised of a resilient rubber material into a bottomed cylindrical shape having an attaching part 51 , a bottom 52 and a pressing part 53 at the circumferential surface.
  • the attaching part 51 is mounted sealingly to the cylindrical outer circumferential surface of the capsule housing/holding lower part 38 of the capsule housing/holding part 30 , and an air inlet valve 54 is attached to a central portion of the bottom 52 .
  • the air intake valve 54 produced using a resilient rubber material is comprised of an air inlet form 55 and an inlet valve body 56 .
  • the valve is closed when the pump 50 is pressed, while the valve is opened upon restoration of the pump 50 after pressing to supply external air to the pump 50 .
  • the powdery medicine delivery device 10 for nasal cavity according to this embodiment has been constituted as described above.
  • the capsule K is placed in the capsule attaching/detaching concave 41 of the capsule setting/detaching part 40 and the capsule setting/attaching end face 46 of the capsule setting/detaching part 40 is pressed so as to intrude the capsule setting/detaching part 40 into the capsule housing/holding part 30 .
  • the capsule setting/detaching end face 46 of the capsule setting/detaching part 40 is pushed to abut the setting/detaching protrusion 45 against the abutment surface 36 of the capsule housing/holding part 30 , the capsule K that was already perforated with holes at both axial ends pass completely through to the medicine passage 21 of the medicine delivery part 20 and the air flow channel 31 of the capsule housing/holding part 30 to be in a state ready for dosing the medicine.
  • the medicine in the capsule K perforated at both axial ends thereof falls toward to the air flow passage 31 . Since the one-way valve 33 is closed, the medicine is captured and collected in the medicine capturing/collecting part 32 .
  • holes are easily perforated at both axial ends of the capsule K only by the operation of housing the capsule K in the device 10 to deliver the powdery medicine into the nasal cavity and the medicine falling and flowing backwardly after perforation is reliably captured by the one-way valve 33 and the medicine capturing/collecting part 22 .
  • the pressure of air loaded on the one-half way valve 33 increases and, when it reaches to a predetermined pressure, the one-way valve 33 is opened in which air is supplied from the pump 50 through the one-way valve 33 , the medicine capturing/collecting part 32 and the air flow channel 31 to the capsule K.
  • air from the pump 50 flows from the inside of the capsule K through the medicine passage 21 and the nozzles 22 A, 22 B to the nasal cavities of the user.
  • the medicine in the capsule K is agitated by air flowing inside the capsule K and is delivered and dosed together with air to the nasal cavities of the user.
  • the medicine that was captured and collected in the medicine capturing/collecting part 32 upon perforation and exists in the medicine capturing/collecting part 32 and in the air flow passage 31 is delivered by air from the pump 50 , and is delivered and dosed together with the medicine in the capsule K to the nasal cavities of the user.
  • a prescribed amount of the medicine filled in the capsule K can be reliably delivered and dosed to the user's nasal cavities.
  • the pressing part 53 of the pump 50 having the rubber resiliency restores in the direction shown by an arrow R to cause a negative pressure in the pump 50 , so that the intake valve body 56 of the air intake valve 54 is opened by the pressure of the external air and air flows into the pump 50 from the outside by way of the air intake hole 55 to restore the pressing portion of the pump 50 to an original state as shown by chain double-dashed lines.
  • the cutting blades 60 A, 60 B situated laterally at both axial ends of the capsule K to the capsule housing/holding part 30 cut off both axial end portions KA, KB of the capsule K to perforate both axial ends of the capsule K. That is, containment of the capsule K and perforation thereof can be conducted with an extremely simple operation consisting only of the operation of housing the capsule K in the device 10 to deliver the powdery medicine into the nasal cavity.
  • the capsule can be perforated reliably to ready for dosing the medicine.
  • the capsule housing/holding part 30 is comprised of the medicine capturing/collecting part 31 for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule K, and the one-way valve 33 also for preventing the falling and backward flowing of the powdery medicine from the capsule K.
  • the one-way valve 33 is adapted such that it opens when the pressure of air from the pump 50 reaches a predetermined pressure, whereas the air flow inlet 35 is closed by the spring 34 when the pressure of air from the pump 50 is lower than the predetermined pressure thereby reliably preventing backward flow of air or medicine.
  • the medicine captured and collected by the medicine capturing/collecting part 32 of the air flow passage 31 and exists therein upon perforation can be delivered and dosed to the user's nasal cavities together with the medicine in the capsule K when the air pressure in the pump 50 increases above the predetermined pressure to open the one-way valve 33 . Accordingly, since this can overcome the problem that the medicine can not be delivered at an adequate dose by the falling of the medicine to the pump from the capsule after the perforation, or a problem that the pump has to be cleaned as in the prior art, a predetermined amount of the medicine filled in the capsule K can reliably be delivered and dosed to the nasal cavities of the user.
  • the medicine passage 21 is built and nozzles 22 A, 22 B comprising flexible tubes are formed to the top end of the medicine passage 21 and they can be inserted for dosing while conforming the user's nasal nostril upon dosing.
  • nozzles 22 A, 22 B comprising flexible tubes are formed to the top end of the medicine passage 21 and they can be inserted for dosing while conforming the user's nasal nostril upon dosing.
  • FIG. 7 is a cross sectional view of a device to deliver the powdery medicine into the nasal cavity according to another embodiment of the present invention (reference numerals in the drawing have same meanings as those in the previous embodiment).
  • This modified embodiment is different from the previous embodiment only in that the nozzle 22 formed of a flexible tube at the top end of the medicine passage 21 comprises a single nozzle in the medicine delivery part 20 , and operation upon perforation to the capsule K and the operation upon dosing the medicine to the user after perforation are quite identical with those of the previous embodiment.
  • the cutting blades situated laterally to the capsule housing/holding part at both axial ends of the capsule cut off both axial ends of the capsule thereby enabling to perforate at both axial ends of the capsule.
  • the present invention can conduct perforation to the capsule reliably by an extremely simple operation without the capsule perforating operation which tends to be forgotten and with no worry of missing separate members such as a cap having a perforating needle or a top end in the prior art, and can perforate the capsule reliably with an extremely simple operation.
  • the device comprises the air flow passage and the medicine capturing/collecting part having a passage shape for capturing and collecting the medicine dropping and flowing backwardly from the capsule after perforation thereby preventing the medicine from falling into the pump and capable of dosing the captured and collected medicine together with the medicine in the capsule by the operation of the pump, and one-way valve controlled to a predetermined opening pressure by the spring are built between the capsule housing/holding part and the pump, the falling and backwardly flowing medicine upon perforation is delivered and dosed to the nasal cavities of the user together with the medicine in the capsule by way of the capsule housing/holding part and the medicine delivery part, and a predetermined amount of the medicine filled in the capsule can reliably be delivered and dosed to the nasal cavities of the user. Further, since the medicine does not drop at all to the pump, cleaning operation for the pump can be saved.
  • the nozzle of the medicine delivery part is formed of a flexible tubes, it can be inserted smoothly while conforming the shape of the user's nasal nostril upon inserting the nozzle into the nasal nostril by the user, efficient dosing can be conducted safely while being conformed with the shape of the user's nasal nostril.

Abstract

Improvement for the device to deliver the powdery medicine into nasal cavities in which a capsule setting/detaching part 40 is built drawably in the capsule housing/holding part 30, and cutting blades 60A, 60B are built in both axial ends of the capsule setting/detaching part 40 of the capsule housing/holding part 30 for cutting both axial ends of the capsule thereby perforating the capsule. A medicine capturing/collecting part 32 and a one-way valve 33 are built in a lower portion of the capsule housing/holding part 30, and a pump 50 having an air inlet valve 54 is built in the air flow inlet side thereof. A medicine delivery part 20 is built in the air exit of the capsule housing/holding part 30, a nozzle 22 is installed and medicine in the capsule can be dosed to the nasal cavities of the user by pressing the pump 50.

Description

TECHNICAL FIELD
The present invention concerns an optimal device to deliver powdery medicine dosing into the nasal cavity.
A treatment method to deliver a powdery medicine into the nasal cavity of a patient suffering from asthma or nasal allergy has been known generally. In the treatment method, a powdery medicine filled in a capsule is administered into the nasal cavity using a special delivery device. JP-A No. 59-34267 (hereinafter referred to as prior art) has proposed a delivery device used for the treatment. The device of the prior art comprises a cylindrical member having a pump on the air inlet and a concave part in which a capsule is inserted on the air exit of the cylindrical member. A top end part is fitted into the concave part to form a capsule housing part, and an air guide passage having a valve mechanism is formed from the capsule housing part to the pump.
Another valve mechanism is provided to the other side of the pump, and air is supplied to the capsule housing part through the air guide passage having a valve mechanism upon pressing of the pump, and external air is sucked into the pump through the another valve upon removal of the pump pressure.
Further, the cylindrical member has, at its top end, a cap fitted to the top end and a needle is extended axially in the cap so as to perforate both axial ends of the capsule by engaging the cap in a state of fitting the concave part of the cylindrical member and the top end having an opening.
In the prior art device of the constitution described above, after inserting the capsule filled with a powdery medicine into the concave part of the cylindrical member, the capsule is inserted and fixed in the capsule housing portion by fitting the top end. Then a cap is fitted to the top end made of a hard resin to perforate at both axial top ends of the capsule by a needle built inside the cap and guided to the top end.
Then, when the medicine is dosed, a user detaches the cap from the cylindrical member and inserts the top end into one of the nasal nostril and presses the pump. Then, when the pump is pressed, air from the pump flows through the air guide passage into the capsule to deliver the medicine in the capsule to the nasal cavity of the user. Further, by repeating the operations for both nasal cavities, the medicine is dosed to both of the nasal cavities.
In the device of the prior art described above, after inserting the capsule in the cylindrical member, the top end is fitted detachably to the cylindrical member and then a cap is detachably provided to the cylindrical member. However, such operations to deliver are troublesome and it may be a worry that the user should forget such operations. Further, in a case where the top end or the cap is missed, it can no more be used as the delivery device.
Further, when the powdery medicine is dropped in the course of operations from perforation to dosing operation in the pump passing through the valve mechanism in the air guide passage, it will bring about a problem that the amount of the medicine is reduced, the medicine can not be delivered at an adequate dose for the user and the medicine dropped in the pump has to be cleaned.
Further, upon dosing of the medicine, the user inserts the top end into the nasal nostril. However, since the top end is made of a rigid resin, it may be a worry of injuring the nasal nostril upon insertion. Further, since the top end does not smoothly fitted to the shape of the user's nostril, this hinders application of medicine to the nasal cavity making it impossible for efficient dosing.
The present invention intends to overcome such problems.
DISCLOSURE OF THE INVENTION
The present invention of claim 1 for solving the problems described above comprises a capsule housing/holding part for housing and holding a capsule filled with a powdery medicine, a pump installed in the capsule housing/holding part for supplying dosing air to the capsule housing/holding part, a medicine delivery part with a top end which may be optionally branched into two ways for delivering the medicine in the capsule loaded into the capsule housing/holding part from the pump to the user's nasal cavity by air supplied through an air flow passage formed in the capsule housing/holding part, a capsule setting/detaching part built drawably in the capsule housing/holding part so as to be movable in the lateral direction relative to the axial direction of the capsule for setting and detaching the capsule thereby perforating at both axial ends of the capsule, and cutting blades built laterally relative to the axial direction of the capsule in the capsule housing/holding part for perforating at both axial ends of the capsule.
The invention of claim 2 comprises a medicine capturing/collecting part having a specific structure of an air flow passage for capturing and collecting a powdery medicine dropping and flowing backwardly from the capsule after perforation so as not to flow the medicine backwardly and capable of dosing the thus captured and collected powdery medicine by the pump actuation, and a one-way valve the opening pressure of which is controlled by a spring.
Further, the invention of claim 3 comprises the nozzle for the medicine spray part constituted with a flexible tube for insertion while conforming the shape of the user's nasal nostril for dosing when the user applies the powdery medicine to the nasal cavity.
More specifically, according to the delivery device for the powdery medicine of claim 1 provided by the present invention, a capsule is placed in the capsule setting/detaching part built drawably so as to move in the lateral direction relative the axial direction of the capsule in the capsule housing/holding part and cutting blades built laterally to the axial direction of the capsule in the capsule housing/holding part perforate at both axial ends of the capsule.
Further, air is supplied from the pump upon dosing and the air flows into the perforated capsule to deliver and dose the medicine in the capsule through the medicine passage in the medicine delivery part from the nozzle to the user's nasal cavity.
Further, in the invention according to claim 2, since the medicine capturing/collecting part, and the one-way valve the opening pressure of which is controlled by the spring are built in the air flow passage between the capsule housing/holding part and the pump, they capture and collect the medicine falling and flowing backwardly from the capsule to the pump upon perforation of the capsule and can prevent falling and backward flow to the pump.
Further, upon dosing, the one-way valve is opened by the flow under pressure of air from the pump to deliver and dose the captured and collected medicine together with the medicine in the capsule by way of the capsule housing/holding part and the medicine delivery part from the nozzle to the user's nasal cavity.
Further according to the invention described more specifically in claim 3, the user inserts the nozzle of the medicine delivery part into the nasal nostril upon dosing the medicine to the nasal cavity. Since the nozzle is made of a flexible tube, it can be inserted conforming the user's nasal nostril.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a side elevational view illustrating an embodiment of a powdery medicine delivery device according to the present invention.
FIG. 2 is a cross sectional view illustrating an embodiment of a powdery medicine delivery device according to the present invention.
FIG. 3 is a view showing a state of drawing out a capsule setting/detaching part and placing a capsule therein in FIG. 2.
FIG. 4 is a cross sectional side elevational view showing a state in which cutting blades are cutting a capsule end in the course where the capsule setting/detaching part with the capsule placed therein is inserted into a capsule housing/holding part.
FIG. 5 is a cross sectional view showing a state in which the capsule end is cut off by cutting blades, and the medicine in the capsule upon completion of perforation is falling and flowing backwardly to the pump in FIG. 2.
FIG. 6 is a cross sectional view in a state where the medicine in the capsule is under delivery and dosing by pressing the pump.
FIG. 7 is a cross sectional view showing another embodiment of a powdery medicine delivery device of the invention.
Each of the references has the following meanings
  • 10 device to deliver the powdery medicine into the nasal cavity
  • 20 medicine delivery part
  • 21 medicine passage
  • 22, 22A, 22B nozzle
  • 30 capsule housing/holding part
  • 31 air flow passage
  • 32 medicine capturing/collecting part
  • 33 one-way valve
  • 34 spring
  • 35 air flow inlet
  • 36 abutment surface
  • 37 protrusion
  • 38 lower portion of the capsule housing/holding part
  • 40 capsule setting/detaching part
  • 41 capsule attaching/detaching concave part
  • 42A, 42B capsule cut end discharge part
  • 44 drawing end
  • 45 protrusion for capsule setting/detaching part
  • 46 end face for capsule setting/detaching part
  • 50 pump
  • 51 attaching part
  • 52 bottom
  • 53 pressing part
  • 54 air intake valve
  • 55 air intake valve
  • 56 intake valve body
  • 60A, 60B cutting blade
  • K capsule
  • KA, KB capsule end
BEST MODE FOR PRACTICING THE INVENTION
The present invention is to be described by way of embodiments with reference to the drawings. An embodiment of the present invention is to be described with reference to FIG. 1 to FIG. 7.
FIG. 1 is a side elevational view of an embodiment of a device to deliver the powdery medicine into the nasal cavity according to the present invention and FIG. 2 is a cross sectional side elevational view of a device to deliver the powdery medicine into the nasal cavity shown in the embodiment.
In the drawings, a powdery medicine delivery device 10 for nasal cavity comprises, generally, a capsule housing/holding part 30 for housing and holding a capsule K together with a medicine delivery part 20, a capsule setting/detaching part 40 built drawably in the capsule housing/holding part 40 and a pump 50 built in the air inlet side of the capsule housing/holding part 30 for supplying air to the capsule, and cutting blades 60a, 60b situated at both axial ends of the capsule K of the capsule setting/detaching part 40 of the capsule housing/holding part 30 for perforating holes at both axial ends of the capsule K by setting/detaching operation of the capsule setting/detaching part 40.
In the medicine delivery part 20 of this embodiment, a medicine passage 21 is built in an upper part (air exit side) with respect to the axial direction of the capsule K of the capsule housing/holding part 30, and nozzles 22A and 22B made of flexible tubes are formed to the top end of the medicine passage 21.
An air flow passage 31 of the capsule housing/holding part 30 axially below the capsule K (air inlet side) includes a medicine capturing/collecting part 32 for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule K, and a one-way valve 30 also preventing falling and backward flowing of the powdery medicine from the capsule K to the pump 50. The one-way valve 33 is adapted to prevent back flow of air such that it opens when the pressure of air from the pump 50 reaches at or higher than a prescribed pressure and closes the air flow inlet 35 when the pressure of air from the pump 50 is lower than the prescribed pressure.
The capsule setting/detaching part 40 has a capsule attaching/detaching recess 41 at a position of attaching or detaching the capsule K, such that it can be set and detached drawably in the lateral direction with respect to the axial direction of the capsule K to the capsule housing/holding part 30 and a drawing end 44 of the capsule setting/detaching part 40 is regulated by the abutment of the detaching end 44 to the protrusion 37 built in the capsule housing/holding part 30.
Further, when the capsule setting/detaching part 40 is pushed into the capsule housing/holding part 30, the inlet end is regulated by the abutment of a setting/detaching protrusion 45 of the capsule setting/detaching part 40 against the abutment face 36 of the capsule housing/holding part 30.
The pump 50 is comprised of a resilient rubber material into a bottomed cylindrical shape having an attaching part 51, a bottom 52 and a pressing part 53 at the circumferential surface. The attaching part 51 is mounted sealingly to the cylindrical outer circumferential surface of the capsule housing/holding lower part 38 of the capsule housing/holding part 30, and an air inlet valve 54 is attached to a central portion of the bottom 52.
The air intake valve 54 produced using a resilient rubber material is comprised of an air inlet form 55 and an inlet valve body 56. The valve is closed when the pump 50 is pressed, while the valve is opened upon restoration of the pump 50 after pressing to supply external air to the pump 50.
The powdery medicine delivery device 10 for nasal cavity according to this embodiment has been constituted as described above.
Then, description is to be made to an operation upon perforation of the capsule with reference to FIG. 3 to FIG. 5.
At first, as shown in FIG. 3, the capsule K is placed in the capsule attaching/detaching concave 41 of the capsule setting/detaching part 40 and the capsule setting/attaching end face 46 of the capsule setting/detaching part 40 is pressed so as to intrude the capsule setting/detaching part 40 into the capsule housing/holding part 30.
Then, as shown in FIG. 4, as the capsule K placed in the capsule setting/detaching concave 41 of the capsule setting/detaching part 40 intrudes into the capsule housing/holding part 30, the cutting blades 60A, 60B built laterally at both axial ends of the capsule K in the capsule housing/holding part 30 cut off both axial ends KA, KB of the capsule K, thereby perforating both ends of the capsule K.
Further, when the capsule setting/detaching end face 46 of the capsule setting/detaching part 40 is pushed to abut the setting/detaching protrusion 45 against the abutment surface 36 of the capsule housing/holding part 30, the capsule K that was already perforated with holes at both axial ends pass completely through to the medicine passage 21 of the medicine delivery part 20 and the air flow channel 31 of the capsule housing/holding part 30 to be in a state ready for dosing the medicine.
In this case, as shown in FIG. 5, the medicine in the capsule K perforated at both axial ends thereof falls toward to the air flow passage 31. Since the one-way valve 33 is closed, the medicine is captured and collected in the medicine capturing/collecting part 32.
As described above, upon perforation in the device 10 to deliver the powdery medicine into the nasal cavity in this embodiment, holes are easily perforated at both axial ends of the capsule K only by the operation of housing the capsule K in the device 10 to deliver the powdery medicine into the nasal cavity and the medicine falling and flowing backwardly after perforation is reliably captured by the one-way valve 33 and the medicine capturing/collecting part 22.
Then, operation upon dosing the medicine to the user after perforation to the capsule K is to be described with reference to FIG. 6.
At first, when the nozzles 22A, 22B of the medicine delivery part 20 are inserted into nasal nostril of a user and the pressing part 53 of the pump 50 is pressed in the direction of an arrow P as shown in FIG. 6, the pressure of air loaded on the one-half way valve 33 increases and, when it reaches to a predetermined pressure, the one-way valve 33 is opened in which air is supplied from the pump 50 through the one-way valve 33, the medicine capturing/collecting part 32 and the air flow channel 31 to the capsule K.
Thus, air from the pump 50 flows from the inside of the capsule K through the medicine passage 21 and the nozzles 22A, 22B to the nasal cavities of the user.
In this process, the medicine in the capsule K is agitated by air flowing inside the capsule K and is delivered and dosed together with air to the nasal cavities of the user.
Further, the medicine that was captured and collected in the medicine capturing/collecting part 32 upon perforation and exists in the medicine capturing/collecting part 32 and in the air flow passage 31 is delivered by air from the pump 50, and is delivered and dosed together with the medicine in the capsule K to the nasal cavities of the user. As a result, a prescribed amount of the medicine filled in the capsule K can be reliably delivered and dosed to the user's nasal cavities.
Further, just before the completion of pressing to the pump 50, pressure of air loaded on the one-way valve 33 is weakened and when it becomes lower than the prescribed pressure to open the one-way valve 33, the one-way valve is closed. Just before the closure of the one-way valve 33, air still flows from the pump 50 to the capsule K. Accordingly, the medicine in the capsule K, the air flow passage 31, and the medicine capturing/collecting part 32 does not fall and flow backwardly to the pump 50 and falling and backward flow of the medicine to the pump 50 can be prevented reliably.
Further, when the pressing to the pump 50 is completed and the pressure is removed, the pressing part 53 of the pump 50 having the rubber resiliency restores in the direction shown by an arrow R to cause a negative pressure in the pump 50, so that the intake valve body 56 of the air intake valve 54 is opened by the pressure of the external air and air flows into the pump 50 from the outside by way of the air intake hole 55 to restore the pressing portion of the pump 50 to an original state as shown by chain double-dashed lines.
In the device 10 to deliver the powdery medicine into the nasal cavity in this embodiment, when the capsule K is placed in the capsule attaching/detaching concave 41 of the capsule setting/detaching part 40 and as the capsule setting/detaching part 40 intrudes in the capsule housing/holding part 30, the cutting blades 60A, 60B situated laterally at both axial ends of the capsule K to the capsule housing/holding part 30 cut off both axial end portions KA, KB of the capsule K to perforate both axial ends of the capsule K. That is, containment of the capsule K and perforation thereof can be conducted with an extremely simple operation consisting only of the operation of housing the capsule K in the device 10 to deliver the powdery medicine into the nasal cavity. In addition, there is no worry of missing the cap for perforation or the top end which was provided as a separate member in the prior art and, further, there is no worry of forgetting the perforating operation which would lead to the dosing failure of the medicine. The capsule can be perforated reliably to ready for dosing the medicine.
Further, the capsule housing/holding part 30 is comprised of the medicine capturing/collecting part 31 for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule K, and the one-way valve 33 also for preventing the falling and backward flowing of the powdery medicine from the capsule K. The one-way valve 33 is adapted such that it opens when the pressure of air from the pump 50 reaches a predetermined pressure, whereas the air flow inlet 35 is closed by the spring 34 when the pressure of air from the pump 50 is lower than the predetermined pressure thereby reliably preventing backward flow of air or medicine. Accordingly, the medicine captured and collected by the medicine capturing/collecting part 32 of the air flow passage 31 and exists therein upon perforation can be delivered and dosed to the user's nasal cavities together with the medicine in the capsule K when the air pressure in the pump 50 increases above the predetermined pressure to open the one-way valve 33. Accordingly, since this can overcome the problem that the medicine can not be delivered at an adequate dose by the falling of the medicine to the pump from the capsule after the perforation, or a problem that the pump has to be cleaned as in the prior art, a predetermined amount of the medicine filled in the capsule K can reliably be delivered and dosed to the nasal cavities of the user.
Further, in the medicine delivery part 20, the medicine passage 21 is built and nozzles 22A, 22B comprising flexible tubes are formed to the top end of the medicine passage 21 and they can be inserted for dosing while conforming the user's nasal nostril upon dosing. As a result, there is neither a worry of injuring the nasal nostril of the user by the insertion of the top ends formed of a rigid resin into the nasal nostril nor a worry that dosing to the nasal cavities is inhibited due to inconformity with the shape of the user's nasal nostril making it impossible for efficient dosing as in the prior art, but efficient dosing can be conducted efficiently in this embodiment while conforming the shape of the user's nasal cavities.
FIG. 7 is a cross sectional view of a device to deliver the powdery medicine into the nasal cavity according to another embodiment of the present invention (reference numerals in the drawing have same meanings as those in the previous embodiment). This modified embodiment is different from the previous embodiment only in that the nozzle 22 formed of a flexible tube at the top end of the medicine passage 21 comprises a single nozzle in the medicine delivery part 20, and operation upon perforation to the capsule K and the operation upon dosing the medicine to the user after perforation are quite identical with those of the previous embodiment.
INDUSTRIAL APPLICABILITY
As has been described above, according to the invention of claim 1, when the capsule is placed in the capsule detaching/attaching concave part of the capsule setting/detaching part and as a capsule setting/detaching part intrudes into the capsule housing/holding part, the cutting blades situated laterally to the capsule housing/holding part at both axial ends of the capsule cut off both axial ends of the capsule thereby enabling to perforate at both axial ends of the capsule. Subsequently, air is supplied from the pump to the capsule in the capsule housing/holding part to dose the medicine in the capsule together with air from the medicine passage of the medicine delivery part by way of the nozzle to the nasal cavities of the user, so that the operations up to the perforation to the capsule can be conducted only by the operation of housing the capsule into the device to deliver the powdery medicine into the nasal cavity. The present invention can conduct perforation to the capsule reliably by an extremely simple operation without the capsule perforating operation which tends to be forgotten and with no worry of missing separate members such as a cap having a perforating needle or a top end in the prior art, and can perforate the capsule reliably with an extremely simple operation.
Further, according to the invention of claim 2, since the device comprises the air flow passage and the medicine capturing/collecting part having a passage shape for capturing and collecting the medicine dropping and flowing backwardly from the capsule after perforation thereby preventing the medicine from falling into the pump and capable of dosing the captured and collected medicine together with the medicine in the capsule by the operation of the pump, and one-way valve controlled to a predetermined opening pressure by the spring are built between the capsule housing/holding part and the pump, the falling and backwardly flowing medicine upon perforation is delivered and dosed to the nasal cavities of the user together with the medicine in the capsule by way of the capsule housing/holding part and the medicine delivery part, and a predetermined amount of the medicine filled in the capsule can reliably be delivered and dosed to the nasal cavities of the user. Further, since the medicine does not drop at all to the pump, cleaning operation for the pump can be saved.
Further according to the invention described in claim 3, since the nozzle of the medicine delivery part is formed of a flexible tubes, it can be inserted smoothly while conforming the shape of the user's nasal nostril upon inserting the nozzle into the nasal nostril by the user, efficient dosing can be conducted safely while being conformed with the shape of the user's nasal nostril.

Claims (38)

The invention claimed is:
1. A device to deliver a powdery medicine into the a nasal cavity, comprising:
a capsule housing/holding part for housing and holding a capsule filled with a powdery medicine,
a pump installed in the capsule housing/holding part for supplying dosing air to the capsule housing/holding part,
a medicine delivery part with one or branched top end installed in the capsule housing/holding part for delivering and dosing the powdery medicine in the capsule of the capsule housing/holding part by air supplied by way of an air flow passage built in the capsule housing/holding part from the pump to the nasal cavity of a user,
a capsule selling/detaching part built in the capsule housing/holding part so as to move the capsule in a lateral direction relative to an axial direction of the capsule for setting and detaching a capsule and for perforating both axial ends of the capsule, and
cutting blades built in the capsule housing/holding part so as to be movable laterally with respect to an axial direction of the capsule for perforating both axial ends of the capsule,
wherein a medicine capturing/collecting part having an air flow passage shape for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule after perforation and not causing them to flow backwardly to the pump, and capable of dosing the captured and collected powdery medicine by the operation of the pump, and a one-way valve the opening pressure of which is controlled by a spring are built in the air flow passage.
2. The device according to claim 1, further comprising a nozzle of the medicine delivery part composed of a flexible tube such that it can be inserted for dosing while conforming the a nasal nostril of a user when the powdery medicine is dosed to the nasal cavities of the user.
3. The device according to claim 1 wherein the medicine delivery part has a top end branched into two ways.
4. A device to deliver a powdery medicine into the a nasal cavity, comprising:
a capsule housing/holding part for housing and holding a capsule filled with a powdery medicine,
a pump comprising an air intake valve and installed in the capsule housing/holding part for supplying dosing air to the capsule housing/holding part,
a medicine delivery part with one or branched top end installed in the capsule housing/holding part for delivering and dosing the powdery medicine in the capsule of the capsule housing/holding part by air supplied by way of an air flow passage built in the capsule housing/holding part from the pump to the nasal cavity of a user,
a capsule setting/detaching part built in the capsule housing/holding part so as to move the capsule in a lateral direction relative to an axial direction of the capsule for setting and detaching a capsule and for perforating both axial ends of the capsule, and
cutting blades built in the capsule housing/holding part so as to be movable laterally with respect to an axial direction of the capsule for perforating both axial ends of the capsule,
wherein a medicine capturing/collecting part having an air flow passage shape for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule after perforation and not causing them to flow backwardly to the pump, and capable of dosing the captured and collected powdery medicine by the operation of the pump, and a one-way valve the opening pressure of which is controlled by a spring are built in the air flow passage, and
wherein the medicine delivery part has a top end branched into two ways.
5. The device according to claim 2, wherein the medicine delivery part has a top end branched into two ways.
6. The device according to claim 4, further comprising a nozzle of the medicine delivery part composed of a flexible tube such that it can be inserted for dosing while conforming the a nasal nostril of a user when the powdery medicine is dosed to the nasal cavities of the user.
7. A device to deliver a powdery medicine, the device comprising:
a) a capsule housing adapted to receive a capsule filled with the powdery medicine having an upstream end and a downstream end;
b) a capsule setting/detaching part movably in communication with the capsule housing adapted to simultaneously load and perforate the capsule;
c) a pump; and
d) a medicine capturing/collecting part having:
an air flow passage shape for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule after perforation and not causing them to flow backwardly to the pump, and capable of dosing the captured and collected powdery medicine by the operation of the pump, and
a one-way valve the opening pressure of which is controlled by a spring built in the air flow passage.
8. The device of claim 7, wherein the capsule setting/detaching part is adapted to move in a lateral direction relative to an axial direction of the capsule.
9. The device of claim 7, wherein the capsule setting/detaching part comprises a capsule attaching/detaching recess for holding the capsule.
10. The device of claim 7, wherein the capsule setting/detaching part has an interior end and an exterior end further comprising an interior end abutment adapted to prevent the complete withdrawal of the capsule setting/detaching part from the capsule housing when the capsule setting/detaching part is moved laterally away from the capsule housing.
11. The device of claim 7, wherein the capsule setting/detaching part is adapted to regulate the insertion depth of the capsule attaching/detaching recess into the capsule housing when the capsule setting/detaching part is moved laterally towards the capsule housing.
12. The device of claim 11, wherein the depth of insertion of the capsule attaching/detaching recess into the capsule housing when the capsule setting/detaching part is moved laterally towards the capsule housing is regulated by the position of the capsule attaching/detaching recess within the capsule/setting detaching part.
13. The device of claim 7, wherein the capsule setting/detaching part has an interior end and an exterior end further comprising an exterior end protrusion adapted to regulate the insertion depth of the capsule setting/detaching part into the capsule housing when the capsule setting/detaching part is moved laterally towards the capsule housing.
14. The device of claim 12 or 13, wherein the capsule housing is adapted to perforate the capsule before the setting/detaching protrusion of the setting/detaching part abuts the capsule housing/holding part.
15. The device of claim 13, wherein the device is adapted so that once the protrusion of the setting/detaching part abuts the capsule housing/holding part, the device is in a ready state for dosing the powdery medicine.
16. The device of claim 7, wherein the capsule housing further comprises one or more cutting blades adapted to perforate at least one axial end of the capsule.
17. The device of claim 16, wherein the one or more cutting blades are situated lateral to the axial direction of the capsule.
18. The device of claim 7, further comprising a medicine delivery part adapted for delivering the powdery medicine to a user having an upstream end and a downstream end.
19. The device of claim 18, further comprising one or more nozzles coupled to downstream end of the medicine delivery part.
20. The device of claim 19, wherein the one or more nozzles are flexible.
21. The device of claim 19, wherein the one or more nozzles conform to a user's nostril.
22. The device of claim 7, wherein the pump is adapted to supply dosing air to disperse the powdery medicine, and coupled to the upstream end of the capsule housing and the one-way valve in communication with the capsule housing.
23. The device of claim 22, wherein the pump is adapted so as not to need cleaning between uses.
24. The device of claim 22, wherein the pump further comprises an air intake valve.
25. The device of claim 22, wherein the pump further comprises a deformable volume adapted to be engaged by a user.
26. The device of claim 7 or 22, wherein the one-way valve comprises an upstream end and a downstream end, wherein the downstream end is coupled to the upstream end of the capsule housing.
27. The device of claim 7 or 22, wherein the upstream end of the one-way valve is coupled to the pump.
28. The device of claim 27, wherein the one-way valve is adapted to open when air from the pump reaches a predetermined pressure.
29. The device of claim 7 or 22, wherein the one-way valve is adapted to capture medicine that falls upstream from a perforated capsule.
30. The device of claim 29, wherein the device is adapted to deliver the captured medicine to the user.
31. The device of claim 29, wherein the one-way valve is further adapted to prevent the upstream flow of medicine into the pump.
32. The device of claim 7, wherein a portion of the air flow passage configured to capture the powdery medicine prevents backward flow of the powdery medicine to the pump.
33. The device of claim 7, wherein the device is capable of dosing the captured powdery medicine.
34. A method for delivering a powdery medicine, the method comprising:
loading a capsule containing the powdery medicine into a delivery device comprising a nozzle, a capsule housing, a capsule setting/detaching part, a pump, and a medicine capturing/collecting part having:
an air flow passage shape for capturing and collecting the powdery medicine falling and flowing backwardly from the capsule after perforation and not causing them to flow backwardly to the pump, and capable of dosing the captured and collected powdery medicine by the operation of the pump, and
a one-way valve the opening pressure of which is controlled by a spring built in the air flow passage,
wherein the loading step simultaneously sets the capsule into the delivery device and perforates the capsule;
positioning at least a portion of the nozzle of the delivery device into a nostril of a user; and
activating the pump, whereby the powder medicine is delivered to the user.
35. The method of claim 34, wherein perforation of the capsule occurs at the axial ends of the capsule.
36. The method of claim 34, wherein perforation of the capsule is by cutting blades.
37. The method of claim 36, wherein the cutting blades are built into the capsule housing.
38. The method of claim 34, wherein the step of activating the pump comprises squeezing the pump.
US12/576,219 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity Expired - Fee Related USRE45404E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/576,219 USRE45404E1 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/550,490 US7278982B2 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity
US12/576,219 USRE45404E1 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity
PCT/JP2003/003852 WO2004087243A1 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/550,490 Reissue US7278982B2 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity

Publications (1)

Publication Number Publication Date
USRE45404E1 true USRE45404E1 (en) 2015-03-03

Family

ID=33105302

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/576,219 Expired - Fee Related USRE45404E1 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity
US10/550,490 Ceased US7278982B2 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/550,490 Ceased US7278982B2 (en) 2003-03-27 2003-03-27 Powder medicine applicator for nasal cavity

Country Status (8)

Country Link
US (2) USRE45404E1 (en)
EP (1) EP1607117A4 (en)
KR (1) KR100974482B1 (en)
CN (1) CN1758930B (en)
AU (1) AU2003220808B2 (en)
CA (1) CA2519287A1 (en)
MX (1) MXPA05010379A (en)
WO (1) WO2004087243A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3950738B2 (en) 2002-05-14 2007-08-01 株式会社 バイオアクティス Nasal powder medicine administration device
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
KR100974482B1 (en) 2003-03-27 2010-08-10 가부시키가이샤 바이오악티스 Powder medicine applicator for nasal cavity
WO2005102429A1 (en) * 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
WO2006016530A1 (en) * 2004-08-10 2006-02-16 Translational Research, Ltd. Transnasal composition having immediate action and high absorbability
JP4908419B2 (en) * 2004-10-06 2012-04-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Dispenser, storage device and powder dispensing method
DE102006006647B3 (en) * 2006-02-14 2007-01-18 Braunform Gmbh Inhaler device for inhalation of powder in container has capsule holding powder, cutting appliance with two blades to cut ends of capsule which is received by movable slide or drum
PT103481B (en) * 2006-05-16 2008-08-01 Hovione Farmaciencia S A INHALER OF SIMPLE USE AND INHALATION METHOD
US7806117B2 (en) * 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
WO2008026730A1 (en) * 2006-08-31 2008-03-06 Hitachi, Ltd. Medicine sprayer
FR2909288B1 (en) * 2006-12-01 2009-02-06 Jose Bensoussan NASAL TIP FOR NASAL SECRETION SUCTION DEVICE AND NASAL SECRET ASPIRATION DEVICE COMPRISING THE NASAL TIP
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US9205240B2 (en) * 2008-12-15 2015-12-08 Profibrix B.V. Powder delivery device
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
GB201021881D0 (en) 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
EP2670462B1 (en) 2011-01-31 2017-11-22 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
JP5772030B2 (en) * 2011-02-08 2015-09-02 ニプロ株式会社 Powder injection device
WO2012149442A2 (en) 2011-04-28 2012-11-01 Mehta Ketan C Nasal rinse tip
AU2012284195C1 (en) * 2011-07-18 2017-06-22 Rhinosystems Inc. Nasal irrigation device and system with faux collapsible cartridge element
JP5840457B2 (en) * 2011-10-31 2016-01-06 株式会社吉野工業所 Nasal spray
CN103285503A (en) * 2013-06-06 2013-09-11 魏永祥 Powder medicament spraying bottle
UA115119U (en) * 2013-12-06 2017-04-10 MANUAL Oral Cavity Irrigator
US11793950B2 (en) * 2016-02-04 2023-10-24 Propel-Air Biopharma, Llc Medicament delivery device and method
JP6726542B2 (en) * 2016-06-30 2020-07-22 株式会社吉野工業所 Powder dispenser
CN109364359B (en) * 2018-11-27 2021-03-26 孔静 Medicine device is spouted to nasal cavity
IT201900016274A1 (en) * 2019-09-13 2021-03-13 3A Health Care S R L DEVICE AND KIT FOR DELIVERY OF A NEBULIZED SUBSTANCE
USD971021S1 (en) * 2020-04-22 2022-11-29 Bayer Healthcare Llc Bottle

Citations (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906950A (en) 1973-04-04 1975-09-23 Isf Spa Inhaling device for powdered medicaments
US4013075A (en) * 1974-07-15 1977-03-22 I.S.F. S.P.A. Inhalers and insufflators having a cutting means
JPS53127553A (en) 1977-04-13 1978-11-07 Asahi Chem Ind Co Ltd Vehicle
JPS5462328A (en) 1977-10-24 1979-05-19 Asahi Chem Ind Co Ltd Additive for cosmetics
US4159345A (en) 1977-04-13 1979-06-26 Fmc Corporation Novel excipient and pharmaceutical composition containing the same
US4226233A (en) * 1978-10-10 1980-10-07 Longevity Products, Inc. Respirators
US4300545A (en) 1980-06-23 1981-11-17 Schering Corporation Method and nozzle for nasal vaccination of immature mammals
JPS5934267A (en) 1982-08-23 1984-02-24 帝人株式会社 Powdery drug applying apparatus
JPS59163313A (en) 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
EP0147755A2 (en) 1983-12-17 1985-07-10 Boehringer Ingelheim Kg Inhalator
JPS60224616A (en) 1984-04-24 1985-11-09 Teijin Ltd Composition for administration through nose
JPS6242888A (en) 1985-08-21 1987-02-24 カシオ計算機株式会社 Integrated circuit card with solar cell
JPS63267731A (en) 1987-04-23 1988-11-04 Asahi Chem Ind Co Ltd Tablet composition
JPH0329146A (en) 1989-06-12 1991-02-07 Grass Valley Group Inc:The Switch controller
US5098907A (en) 1989-01-24 1992-03-24 Ishihara Sangyo Kaisha Ltd. Powdery pharmaceutical composition containing benzoyl urea, a dispersant and silicic acid
JPH0532560A (en) 1991-08-01 1993-02-09 Teijin Ltd Stabilized pharmaceutical composition of calcitonins
WO1994004133A1 (en) 1992-08-14 1994-03-03 Rhone-Poulenc Rorer Limited Inhalation powder containing antistatic agent
US5320094A (en) 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
WO1995012399A1 (en) 1993-11-01 1995-05-11 Pharmacia Ab Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
US5419315A (en) 1993-01-29 1995-05-30 Aradigm Corporation Intrapulmonary delivery of hormones
JPH07165613A (en) 1993-10-19 1995-06-27 Dot:Kk Carrier for nasal absorption medicine and physiologically active peptide composition
WO1995034582A1 (en) 1994-06-16 1995-12-21 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
JPH0898888A (en) 1994-09-30 1996-04-16 Teijin Ltd Powdery medicine spraying and dosing device
JPH08206208A (en) 1995-02-06 1996-08-13 Unisia Jecs Corp Administrator for nasal cavity
JPH08243164A (en) 1995-03-13 1996-09-24 Unisia Jecs Corp Medicating device for nostril
EP0761248A1 (en) 1995-03-10 1997-03-12 Unisia Jecs Corporation Intranasal medicator
US5647349A (en) * 1995-06-01 1997-07-15 Unisia Jecs Corporation Medicine administering inhaling device
WO1997031626A1 (en) 1996-02-27 1997-09-04 Teijin Limited Powdery composition for nasal administration
US5672581A (en) 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5674507A (en) 1992-12-14 1997-10-07 Biocontrol, Inc. Low crystallinity cellulose excipients
JPH09276405A (en) 1996-04-15 1997-10-28 Unisia Jecs Corp Administrator for nasal cavity
US5683361A (en) * 1991-12-10 1997-11-04 Novo Nordisk A/S Disposable dispenser for powder
JPH09291026A (en) 1996-02-28 1997-11-11 Teijin Ltd Powdery composition for nasal administration having both of rapid action and persistency
JPH1059841A (en) 1996-02-27 1998-03-03 Teijin Ltd Powdery dermal administration composition improved in absorbing property
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5756483A (en) 1993-03-26 1998-05-26 Merkus; Franciscus W. H. M. Pharmaceutical compositions for intranasal administration of apomorphine
WO1998030207A1 (en) 1997-01-14 1998-07-16 Danbiosyst Uk Limited Chitosan-gelatin a microparticles
US5810004A (en) * 1995-10-09 1998-09-22 Unisia Jecs Corporation Medicator for a capsule filled with a powdered drug
WO1999016422A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
WO1999016470A1 (en) 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral preparation
JPH11216357A (en) 1998-02-03 1999-08-10 Tsutsumi Techno Planning Kk Adsorbing carrier for biologically active substance
US5942242A (en) 1995-07-12 1999-08-24 Ltt Institute Co., Ltd Medicaments for nasal administration
US5948749A (en) 1996-10-07 1999-09-07 Fuji Yakuhin Company, Limited Pharmaceutical preparations for intranasal administration
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
WO1999051205A1 (en) 1998-04-03 1999-10-14 University College Cardiff Consultants Limited Aerosol composition
US5989217A (en) 1996-03-21 1999-11-23 Unisia Jecs Corporation Medicine administering device for nasal cavities
JPH11322582A (en) 1998-05-06 1999-11-24 Dot:Kk Nasal mucosal sticking and retention type carrier for pernasal absorption
WO2000012136A1 (en) 1998-08-26 2000-03-09 Teijin Limited Powdery pernasal compositions
WO2000012063A1 (en) 1998-08-26 2000-03-09 Teijin Limited Powdery pernasal compositions
WO2000023023A1 (en) 1998-10-20 2000-04-27 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000038811A1 (en) 1998-12-24 2000-07-06 Glaxo Group Limited Apparatus and process for preparing crystalline particles
JP2000229859A (en) 1999-02-12 2000-08-22 Teijin Ltd Stable pernasal preparation of buprenorphine
JP2000239187A (en) 1999-02-22 2000-09-05 Dotto:Kk Transnasal absorption composition
US6136295A (en) 1996-05-24 2000-10-24 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
JP2001055323A (en) 1999-08-12 2001-02-27 Teijin Ltd Powdery composition for nasal administration
US6197328B1 (en) 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions
WO2001026630A1 (en) 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
WO2001032125A2 (en) 1999-11-03 2001-05-10 Glaxo Group Limited Apparatus and process for preparing crystalline particles
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6273086B1 (en) * 1998-02-06 2001-08-14 Unisia Jecs Corporation Inhalant medicator
US20010027301A1 (en) 1999-10-14 2001-10-04 Steven Lau Controlled-dose dispenser with integral nozzle and cap
US6298846B1 (en) * 1997-01-30 2001-10-09 Unisia Jecs Corporation Suction type medicator
US20010038824A1 (en) 2000-01-20 2001-11-08 Ikuo Horii Intranasal cyclic peptide formulations
US20020002172A1 (en) 1998-05-15 2002-01-03 Cristi L. Bell-Huff Pharmaceutical formulations
US20020040139A1 (en) 1998-06-22 2002-04-04 Anne Billotte Intranasal formulations for treating sexual disorders
WO2002032406A2 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20020062829A1 (en) 2000-11-27 2002-05-30 Unisia Jecs Corporation Inhalator, a powder composition and a process for administering the powder composition using inhalators
JP2002255795A (en) 2001-02-26 2002-09-11 Teijin Ltd Composition for pernasal administration
WO2002094233A1 (en) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of antiemetics through an inhalation route
WO2003004048A1 (en) 2001-07-05 2003-01-16 Translational Research Ltd. Compositions for nasal administration of insulin
US6516795B1 (en) * 1997-11-17 2003-02-11 Rexam Sofab Nose sprayer
WO2003030872A2 (en) 2001-10-12 2003-04-17 Elan Pharma International Ltd. Compositions having a combination of particles for immediate release and for controlled release
JP2003154006A (en) 2001-11-19 2003-05-27 Bioactis:Kk Powdery medicine dispensing device for nasal cavity
JP2003175103A (en) 2001-12-12 2003-06-24 Teijin Ltd Powder medicine many-time medicator
JP2003206227A (en) 2002-01-09 2003-07-22 Translational Research株式会社 Medicinal composition for nasal administration
WO2003077825A2 (en) 2002-03-12 2003-09-25 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
US20030199424A1 (en) 2002-03-20 2003-10-23 Smith Maree Therese Method of treatment and/or prophylaxis
WO2003095008A1 (en) 2002-05-14 2003-11-20 Bioactis Limited Powder chemical feeding device for nasal cavity
WO2004004922A1 (en) 2002-07-09 2004-01-15 Optinose As Delivery devices
US20040076588A1 (en) 2002-06-28 2004-04-22 Batycky Richard P. Inhalable epinephrine
US20040092428A1 (en) 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
GB2395900A (en) 2002-12-04 2004-06-09 Elan Drug Delivery Ltd Therapeutic composition for respiratory delivery
WO2004073729A1 (en) 2003-02-21 2004-09-02 Translational Research Ltd. Compositions for nasal administration of drug
EP1454648A1 (en) 2003-03-05 2004-09-08 Hitachi Unisia Automotive Ltd. Medicine administering device for nasal cavities
US20040173211A1 (en) * 2003-01-14 2004-09-09 Boehringer Ingelheim International Gmbh Powder inhaler
US6815424B2 (en) 1987-10-15 2004-11-09 Pfizer Corporation Intranasal administration of polypeptides in powdered form
US6824080B2 (en) 2000-06-12 2004-11-30 Teijin Limited Powdered medicine multi-dose administering device
US20040241232A1 (en) 2001-09-17 2004-12-02 Brown Andrew Bruce Dry powder medicament formulations
US20050022812A1 (en) 2003-06-13 2005-02-03 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
US6855913B2 (en) 2002-08-06 2005-02-15 Hobart Brothers Company Flux-cored wire formulation for welding
WO2005013937A2 (en) 2003-07-23 2005-02-17 Elan Pharma International Ltd. Novel compositions of sildenafil free base
WO2005056008A1 (en) 2003-12-05 2005-06-23 Archimedes Development Limited Intranasal compositions
WO2005104712A2 (en) 2004-04-23 2005-11-10 Cydex, Inc. Dpi formulation containing sulfoalkyl ether cyclodextrin
WO2006016530A1 (en) 2004-08-10 2006-02-16 Translational Research, Ltd. Transnasal composition having immediate action and high absorbability
WO2006040680A1 (en) 2004-10-15 2006-04-20 Pfizer Products Inc. Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
US20060106057A1 (en) 1998-06-05 2006-05-18 Warner-Lambert Company. Llc Stabilization of quinapril using magnesium oxide
US20060116657A1 (en) 2003-03-21 2006-06-01 Daniel Schmid Mixing capsule
US20060217658A1 (en) 2003-03-27 2006-09-28 Tatsuo Tsutsui Power medicine applicator for nasal cavity
US20060216352A1 (en) 2003-01-31 2006-09-28 Orexo Ab Rapid-acting pharmaceutical composition
US7115281B2 (en) 2002-07-08 2006-10-03 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
US20070055200A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Needle-free jet injection drug delivery device
US20070060868A1 (en) 2003-10-09 2007-03-15 Bioactis Limited Device to deliver a powdery medicine into nasal cavity
US20070065509A1 (en) 2000-06-26 2007-03-22 Bayer Healthcare Aktiengesellschaft Method of preparing sustained-release preparations of quinolone antibiotics
US20070098804A1 (en) 2005-08-29 2007-05-03 Judith Aronhime Solid particulate tadalafil having a bimodal particle size distribution
JP3912469B2 (en) 1999-05-13 2007-05-09 セイコーエプソン株式会社 Forged printed matter judgment ink
US20070178164A1 (en) 2006-01-31 2007-08-02 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
US20070184109A1 (en) 2003-06-06 2007-08-09 Floyd Alison G Compositions comprising triptans and nsaids
US20070249674A1 (en) 2006-04-25 2007-10-25 Jennifer Bolton Crystalline forms of a dimethylphenyl compound
US20070272763A1 (en) 2004-10-06 2007-11-29 Boehringer Ingelheim International Gmbh Dispensing Device, Storage Device and Method for Dispensing Powder
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US20080031959A1 (en) 2006-07-28 2008-02-07 Blondino Frank E Anti-migraine oral spray formulations and methods
US20080029084A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Device for improved peptide delivery
WO2008031028A2 (en) 2006-09-07 2008-03-13 Parion Sciences, Inc. Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
US20080127972A1 (en) 2004-11-23 2008-06-05 Vectura Limited Dry Powder Inhaler Formulations Comprising Surface-Modified Particles With Anti-Adherent Additives
WO2008075102A1 (en) 2006-12-19 2008-06-26 Pharmakodex Limited Pharmaceutical compositions for transmucusal delivery of a therapeutically active agent on the basis of submicron particles
WO2008078730A1 (en) 2006-12-26 2008-07-03 Translational Research, Ltd. Preparation for transnasal application
US20080286362A1 (en) 2005-08-05 2008-11-20 Baran Jr Jimmie R Compositions Exhibiting Improved Flowability
US20090157037A1 (en) 2007-10-12 2009-06-18 Laxmi Iyer Inhalation drug delivery
WO2009095684A1 (en) 2008-02-01 2009-08-06 Vectura Limited Pulmonary formulations of triptans
US7806117B2 (en) 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
US20110033544A1 (en) 2009-05-15 2011-02-10 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetcs
US20110045088A1 (en) 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177095A (en) * 1876-05-09 Improvement in slow-closing compression-cocks
JP2539333Y2 (en) * 1989-04-03 1997-06-25 オムロン株式会社 Inhaler
IT1230313B (en) * 1989-07-07 1991-10-18 Somova Spa INHALER FOR CAPSULES MEDICATIONS.
US5901703A (en) * 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities

Patent Citations (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906950A (en) 1973-04-04 1975-09-23 Isf Spa Inhaling device for powdered medicaments
US4013075A (en) * 1974-07-15 1977-03-22 I.S.F. S.P.A. Inhalers and insufflators having a cutting means
JPS53127553A (en) 1977-04-13 1978-11-07 Asahi Chem Ind Co Ltd Vehicle
US4159345A (en) 1977-04-13 1979-06-26 Fmc Corporation Novel excipient and pharmaceutical composition containing the same
JPS5462328A (en) 1977-10-24 1979-05-19 Asahi Chem Ind Co Ltd Additive for cosmetics
US4226233A (en) * 1978-10-10 1980-10-07 Longevity Products, Inc. Respirators
US4300545A (en) 1980-06-23 1981-11-17 Schering Corporation Method and nozzle for nasal vaccination of immature mammals
JPS5934267A (en) 1982-08-23 1984-02-24 帝人株式会社 Powdery drug applying apparatus
JPS59163313A (en) 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
EP0122036A1 (en) 1983-03-09 1984-10-17 Teijin Limited Powdery pharmaceutical composition for nasal administration
US4613500A (en) 1983-03-09 1986-09-23 Teijin Limited Powdery pharmaceutical composition for nasal administration
EP0147755A2 (en) 1983-12-17 1985-07-10 Boehringer Ingelheim Kg Inhalator
JPS60185564A (en) 1983-12-17 1985-09-21 ベ−リンガ− インゲルハイム コマンデイツト ゲゼルシヤフト Inhalator
US4889114A (en) * 1983-12-17 1989-12-26 Boehringer Ingelheim Kg Powdered pharmaceutical inhaler
JPS60224616A (en) 1984-04-24 1985-11-09 Teijin Ltd Composition for administration through nose
JPS6242888A (en) 1985-08-21 1987-02-24 カシオ計算機株式会社 Integrated circuit card with solar cell
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
JPS63267731A (en) 1987-04-23 1988-11-04 Asahi Chem Ind Co Ltd Tablet composition
US6815424B2 (en) 1987-10-15 2004-11-09 Pfizer Corporation Intranasal administration of polypeptides in powdered form
US5098907A (en) 1989-01-24 1992-03-24 Ishihara Sangyo Kaisha Ltd. Powdery pharmaceutical composition containing benzoyl urea, a dispersant and silicic acid
JPH0329146A (en) 1989-06-12 1991-02-07 Grass Valley Group Inc:The Switch controller
JPH0532560A (en) 1991-08-01 1993-02-09 Teijin Ltd Stabilized pharmaceutical composition of calcitonins
US5683361A (en) * 1991-12-10 1997-11-04 Novo Nordisk A/S Disposable dispenser for powder
US5320094A (en) 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
WO1994004133A1 (en) 1992-08-14 1994-03-03 Rhone-Poulenc Rorer Limited Inhalation powder containing antistatic agent
US5674507A (en) 1992-12-14 1997-10-07 Biocontrol, Inc. Low crystallinity cellulose excipients
US5419315A (en) 1993-01-29 1995-05-30 Aradigm Corporation Intrapulmonary delivery of hormones
US5672581A (en) 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5756483A (en) 1993-03-26 1998-05-26 Merkus; Franciscus W. H. M. Pharmaceutical compositions for intranasal administration of apomorphine
JPH07165613A (en) 1993-10-19 1995-06-27 Dot:Kk Carrier for nasal absorption medicine and physiologically active peptide composition
US5939100A (en) 1993-11-01 1999-08-17 Pharmacia And Upjohn Ab Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
WO1995012399A1 (en) 1993-11-01 1995-05-11 Pharmacia Ab Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
WO1995034582A1 (en) 1994-06-16 1995-12-21 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
US5804209A (en) 1994-06-16 1998-09-08 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
JPH0898888A (en) 1994-09-30 1996-04-16 Teijin Ltd Powdery medicine spraying and dosing device
JPH08206208A (en) 1995-02-06 1996-08-13 Unisia Jecs Corp Administrator for nasal cavity
EP0761248A1 (en) 1995-03-10 1997-03-12 Unisia Jecs Corporation Intranasal medicator
JPH08243164A (en) 1995-03-13 1996-09-24 Unisia Jecs Corp Medicating device for nostril
US5647349A (en) * 1995-06-01 1997-07-15 Unisia Jecs Corporation Medicine administering inhaling device
US5942242A (en) 1995-07-12 1999-08-24 Ltt Institute Co., Ltd Medicaments for nasal administration
US5810004A (en) * 1995-10-09 1998-09-22 Unisia Jecs Corporation Medicator for a capsule filled with a powdered drug
JPH1059841A (en) 1996-02-27 1998-03-03 Teijin Ltd Powdery dermal administration composition improved in absorbing property
WO1997031626A1 (en) 1996-02-27 1997-09-04 Teijin Limited Powdery composition for nasal administration
US20020012688A1 (en) 1996-02-27 2002-01-31 Masahiko Dohi Powdery composition for nasal administration
EP0943326A1 (en) 1996-02-27 1999-09-22 Teijin Limited Powdery composition for nasal administration
JPH09291026A (en) 1996-02-28 1997-11-11 Teijin Ltd Powdery composition for nasal administration having both of rapid action and persistency
US5989217A (en) 1996-03-21 1999-11-23 Unisia Jecs Corporation Medicine administering device for nasal cavities
JPH09276405A (en) 1996-04-15 1997-10-28 Unisia Jecs Corp Administrator for nasal cavity
US6136295A (en) 1996-05-24 2000-10-24 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5948749A (en) 1996-10-07 1999-09-07 Fuji Yakuhin Company, Limited Pharmaceutical preparations for intranasal administration
WO1998030207A1 (en) 1997-01-14 1998-07-16 Danbiosyst Uk Limited Chitosan-gelatin a microparticles
US6298846B1 (en) * 1997-01-30 2001-10-09 Unisia Jecs Corporation Suction type medicator
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
WO1999016422A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
WO1999016470A1 (en) 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral preparation
US6516795B1 (en) * 1997-11-17 2003-02-11 Rexam Sofab Nose sprayer
JPH11216357A (en) 1998-02-03 1999-08-10 Tsutsumi Techno Planning Kk Adsorbing carrier for biologically active substance
US6273086B1 (en) * 1998-02-06 2001-08-14 Unisia Jecs Corporation Inhalant medicator
WO1999051205A1 (en) 1998-04-03 1999-10-14 University College Cardiff Consultants Limited Aerosol composition
JPH11322582A (en) 1998-05-06 1999-11-24 Dot:Kk Nasal mucosal sticking and retention type carrier for pernasal absorption
US20020002172A1 (en) 1998-05-15 2002-01-03 Cristi L. Bell-Huff Pharmaceutical formulations
US20060106057A1 (en) 1998-06-05 2006-05-18 Warner-Lambert Company. Llc Stabilization of quinapril using magnesium oxide
US20020040139A1 (en) 1998-06-22 2002-04-04 Anne Billotte Intranasal formulations for treating sexual disorders
US6835389B1 (en) 1998-08-26 2004-12-28 Teijin Limited Powder Composition for nasal administration
WO2000012063A1 (en) 1998-08-26 2000-03-09 Teijin Limited Powdery pernasal compositions
EP1108423A1 (en) 1998-08-26 2001-06-20 Teijin Limited Powdery pernasal compositions
WO2000012136A1 (en) 1998-08-26 2000-03-09 Teijin Limited Powdery pernasal compositions
EP1025859A1 (en) 1998-08-26 2000-08-09 Teijin Limited Powdery pernasal compositions
WO2000023023A1 (en) 1998-10-20 2000-04-27 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000038811A1 (en) 1998-12-24 2000-07-06 Glaxo Group Limited Apparatus and process for preparing crystalline particles
JP2000229859A (en) 1999-02-12 2000-08-22 Teijin Ltd Stable pernasal preparation of buprenorphine
JP2000239187A (en) 1999-02-22 2000-09-05 Dotto:Kk Transnasal absorption composition
JP3912469B2 (en) 1999-05-13 2007-05-09 セイコーエプソン株式会社 Forged printed matter judgment ink
JP2001055323A (en) 1999-08-12 2001-02-27 Teijin Ltd Powdery composition for nasal administration
US6197328B1 (en) 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions
WO2001026630A1 (en) 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
US20010027301A1 (en) 1999-10-14 2001-10-04 Steven Lau Controlled-dose dispenser with integral nozzle and cap
WO2001032125A2 (en) 1999-11-03 2001-05-10 Glaxo Group Limited Apparatus and process for preparing crystalline particles
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20010038824A1 (en) 2000-01-20 2001-11-08 Ikuo Horii Intranasal cyclic peptide formulations
US6824080B2 (en) 2000-06-12 2004-11-30 Teijin Limited Powdered medicine multi-dose administering device
US20070065509A1 (en) 2000-06-26 2007-03-22 Bayer Healthcare Aktiengesellschaft Method of preparing sustained-release preparations of quinolone antibiotics
WO2002032406A2 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20020062829A1 (en) 2000-11-27 2002-05-30 Unisia Jecs Corporation Inhalator, a powder composition and a process for administering the powder composition using inhalators
JP2002255795A (en) 2001-02-26 2002-09-11 Teijin Ltd Composition for pernasal administration
WO2002094233A1 (en) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of antiemetics through an inhalation route
US6906027B2 (en) 2001-07-05 2005-06-14 Translational Research Ltd. Composition for nasal administration of insulin
US20040063615A1 (en) 2001-07-05 2004-04-01 Toshikazu Oki Composition for nasal administration of insulin
WO2003004048A1 (en) 2001-07-05 2003-01-16 Translational Research Ltd. Compositions for nasal administration of insulin
US20040241232A1 (en) 2001-09-17 2004-12-02 Brown Andrew Bruce Dry powder medicament formulations
WO2003030872A2 (en) 2001-10-12 2003-04-17 Elan Pharma International Ltd. Compositions having a combination of particles for immediate release and for controlled release
JP2003154006A (en) 2001-11-19 2003-05-27 Bioactis:Kk Powdery medicine dispensing device for nasal cavity
US20040092428A1 (en) 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
JP2003175103A (en) 2001-12-12 2003-06-24 Teijin Ltd Powder medicine many-time medicator
JP2003206227A (en) 2002-01-09 2003-07-22 Translational Research株式会社 Medicinal composition for nasal administration
WO2003077825A2 (en) 2002-03-12 2003-09-25 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
US20030199424A1 (en) 2002-03-20 2003-10-23 Smith Maree Therese Method of treatment and/or prophylaxis
WO2003095008A1 (en) 2002-05-14 2003-11-20 Bioactis Limited Powder chemical feeding device for nasal cavity
US7353823B2 (en) 2002-05-14 2008-04-08 Bioactis Limited Powder chemical feeding device for nasal cavity
EP1504780A1 (en) 2002-05-14 2005-02-09 Bioactis Limited Powder chemical feeding device for nasal cavity
US20050177095A1 (en) 2002-05-14 2005-08-11 Tatsuo Tsutsui Powder chemical feeding device for nasal cavity
US20040076588A1 (en) 2002-06-28 2004-04-22 Batycky Richard P. Inhalable epinephrine
US7115281B2 (en) 2002-07-08 2006-10-03 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
WO2004004922A1 (en) 2002-07-09 2004-01-15 Optinose As Delivery devices
US6855913B2 (en) 2002-08-06 2005-02-15 Hobart Brothers Company Flux-cored wire formulation for welding
GB2395900A (en) 2002-12-04 2004-06-09 Elan Drug Delivery Ltd Therapeutic composition for respiratory delivery
US20040173211A1 (en) * 2003-01-14 2004-09-09 Boehringer Ingelheim International Gmbh Powder inhaler
US20060216352A1 (en) 2003-01-31 2006-09-28 Orexo Ab Rapid-acting pharmaceutical composition
US20060233715A1 (en) 2003-02-21 2006-10-19 Toshikazu Oki Compositions for nasal administration of drug
WO2004073729A1 (en) 2003-02-21 2004-09-02 Translational Research Ltd. Compositions for nasal administration of drug
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
US20130287852A1 (en) 2003-02-21 2013-10-31 Shin Nippon Biomedical Laboratories, Ltd. Compositions for nasal administration of pharmaceuticals
US20090169640A1 (en) 2003-02-21 2009-07-02 Translational Research, Ltd. Compositons for nasal administration of pharmaceuticals
EP1454648A1 (en) 2003-03-05 2004-09-08 Hitachi Unisia Automotive Ltd. Medicine administering device for nasal cavities
US20060116657A1 (en) 2003-03-21 2006-06-01 Daniel Schmid Mixing capsule
US20060217658A1 (en) 2003-03-27 2006-09-28 Tatsuo Tsutsui Power medicine applicator for nasal cavity
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
US20070184109A1 (en) 2003-06-06 2007-08-09 Floyd Alison G Compositions comprising triptans and nsaids
US20050022812A1 (en) 2003-06-13 2005-02-03 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
WO2005013937A2 (en) 2003-07-23 2005-02-17 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US20050042177A1 (en) 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US20070060868A1 (en) 2003-10-09 2007-03-15 Bioactis Limited Device to deliver a powdery medicine into nasal cavity
WO2005056008A1 (en) 2003-12-05 2005-06-23 Archimedes Development Limited Intranasal compositions
US20050142073A1 (en) 2003-12-05 2005-06-30 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Ltd. Intranasal compositions
WO2005104712A2 (en) 2004-04-23 2005-11-10 Cydex, Inc. Dpi formulation containing sulfoalkyl ether cyclodextrin
EP1785145A1 (en) 2004-08-10 2007-05-16 Translational Research, Ltd. Transnasal composition having immediate action and high absorbability
US20080260848A1 (en) 2004-08-10 2008-10-23 Translational Research, Ltd., Compositions that Enable Rapid-Acting and Highly Absorptive Intranasal Administration
WO2006016530A1 (en) 2004-08-10 2006-02-16 Translational Research, Ltd. Transnasal composition having immediate action and high absorbability
US20070272763A1 (en) 2004-10-06 2007-11-29 Boehringer Ingelheim International Gmbh Dispensing Device, Storage Device and Method for Dispensing Powder
WO2006040680A1 (en) 2004-10-15 2006-04-20 Pfizer Products Inc. Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
US20080127972A1 (en) 2004-11-23 2008-06-05 Vectura Limited Dry Powder Inhaler Formulations Comprising Surface-Modified Particles With Anti-Adherent Additives
US20080286362A1 (en) 2005-08-05 2008-11-20 Baran Jr Jimmie R Compositions Exhibiting Improved Flowability
US20070055200A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Needle-free jet injection drug delivery device
US20070098804A1 (en) 2005-08-29 2007-05-03 Judith Aronhime Solid particulate tadalafil having a bimodal particle size distribution
US20070178164A1 (en) 2006-01-31 2007-08-02 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
US20070249674A1 (en) 2006-04-25 2007-10-25 Jennifer Bolton Crystalline forms of a dimethylphenyl compound
US7806117B2 (en) 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
US20080031959A1 (en) 2006-07-28 2008-02-07 Blondino Frank E Anti-migraine oral spray formulations and methods
US20080029084A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Device for improved peptide delivery
WO2008031028A3 (en) 2006-09-07 2008-11-13 Parion Sciences Inc Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
US20080090841A1 (en) 2006-09-07 2008-04-17 Parion Sciences, Inc. Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
WO2008031028A2 (en) 2006-09-07 2008-03-13 Parion Sciences, Inc. Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
WO2008075102A1 (en) 2006-12-19 2008-06-26 Pharmakodex Limited Pharmaceutical compositions for transmucusal delivery of a therapeutically active agent on the basis of submicron particles
WO2008078730A1 (en) 2006-12-26 2008-07-03 Translational Research, Ltd. Preparation for transnasal application
US20100178331A1 (en) 2006-12-26 2010-07-15 Ryoichi Nagata Preparation for transnasal application
US20090157037A1 (en) 2007-10-12 2009-06-18 Laxmi Iyer Inhalation drug delivery
WO2009095684A1 (en) 2008-02-01 2009-08-06 Vectura Limited Pulmonary formulations of triptans
US20110033544A1 (en) 2009-05-15 2011-02-10 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetcs
US20110045088A1 (en) 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator

Non-Patent Citations (48)

* Cited by examiner, † Cited by third party
Title
"Fluorouracil" definition viewed on the National Cancer Institute website at www.cancergov/drugdictionary?cdrid=43130 on May 31, 2012.
Advisory action dated Sep. 13, 2013 for U.S Appl. No. 12/848,850.
Component definition, Dictionary.com, accessed Apr. 1, 2014, pp. 1-4.
English Language Abstract of JP 8-098888.
English Language Abstract of JP 9-276405.
European search report and opinion dated Dec. 19, 2011 for Application No. 07860016.0.
European search report and opinion mailed Dec. 20, 2013 for Application No. 10774745.3.
European search report dated Jul. 15, 2008 for Application No. 05768543.0.
Hens, et al., "BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction," Development 2007, 234, pp. 1221-1230.
Hibberd, et al. Immunization strategies for the immunocompromised host: the need for immunoadjuvants. Ann Intern Med. Jun. 15, 1989;110(12):955-6.
International search report (partial) dated Dec. 21, 2010 for PCT Application No. IB2010/02168.
International search report and written opinion dated Jun. 28, 2011 for PCT Application No. IB2010/02168.
International search report dated Feb. 5, 2008 for PCT Application No. JP2007/074787.
International search report dated May 7, 2003 for PCT Application No. JP2003/001948.
International search report dated Nov. 1, 2005 for PCT Application No. JP2005/014389.
International search report Jun. 8, 2010 for PCT Application No. JP2010/003285.
Ishikawa, et al. Improved nasal bioavailability of elcatonin by insoluble powder formulation. Int J Pharm. Aug. 14, 2001;224(1-2):105-14.
Kleinebudde, et al. Influence of degree of polymerization on behavior of cellulose during homogenization and extrusion/spheronization. AAPS Pharmasci 2000, 2(2) Article 21, 1-10.
Labiris, et al. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. Dec. 2003;56(6):588-99.
Merriam-Webster's Collegiate Dictionary, 10th edition, Merriam-Webster Incorporated: Springfield, Massachusetts, 1993, pp. 41.
Office action dated Apr. 20, 2012 for U.S. Appl. No. 12/780,433.
Office action dated Apr. 8, 2014 for U.S. Appl. No. 13/827,859.
Office action dated Apr. 9, 2014 for U.S. Appl. No. 12/780,433.
Office action dated Dec. 5, 2011 for U.S. Appl. No. 12/346,537.
Office action dated Jan. 13, 2011 for U.S. Appl. No. 12/346,537.
Office action dated Jan. 29, 2008 for U.S. Appl. No. 10/545,764.
Office action dated Jun. 25, 2012 for U.S. Appl. No. 12/346,537.
Office action dated Jun. 4, 2012 for U.S. Appl. No. 12/521,116.
Office action dated Mar. 4, 2013 for U.S. Appl. No. 12/848,850.
Office action dated May 7, 2013 for U.S. Appl. No. 11/660,131.
Office action dated Nov. 1, 2012 for U.S. Appl. No. 11/660,131.
Office action dated Oct. 10, 2012 for U.S. Appl. No. 12/780,433.
Office action dated Oct. 15, 2012 for U.S. Appl. No. 12/848,850.
Office action dated Oct. 29, 2009 for U.S. Appl. No. 11/660,131.
Office action dated Sep. 20, 2013 for U.S. Appl. No. 13/827,859.
Office action dated Sep. 24, 2008 for U.S. Appl. No. 10/545,764.
Office action dated Sep. 27, 2010 for U.S. Appl. No. 11/660,131.
Office action dated Sep. 28, 2011 for JP Application No. 2006-531575 (in Japanese with English translation).
Office action dated Sep. 6, 2011 for U.S. Appl. No. 12/346,537.
Partial English Language Translation of JP 3-29146.
Partial English Language Translation of JP 59-34267.
Partition Coefficient, Wikipedia, accessed Mar. 31, 2014, pp. 1-8.
Rowe, et al (Eds). Handbook of Pharmaceutical Excipients. Pharmaceutical Press. 2003. pp. 108-109.
Topliss, John. Quantitative Structure-Activity Relationships of Drugs, 1983, pp. 2.
U.S. Appl. No. 10/512,857, in the name of Tatsu Tsuisui, filed May 13, 2003.
U.S. Appl. No. 13/649,515, filed Oct. 11, 2012, Nagata et al.
UK combined office action and search report dated Nov. 10, 2010 for Application No. GB1012959.1.
UK search report dated Sep. 9, 2011 for Application No. GB1012959.1.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Also Published As

Publication number Publication date
CN1758930A (en) 2006-04-12
KR100974482B1 (en) 2010-08-10
EP1607117A4 (en) 2007-10-24
MXPA05010379A (en) 2006-05-31
CA2519287A1 (en) 2004-10-14
CN1758930B (en) 2010-06-09
EP1607117A1 (en) 2005-12-21
US7278982B2 (en) 2007-10-09
WO2004087243A1 (en) 2004-10-14
AU2003220808B2 (en) 2008-08-21
US20060217658A1 (en) 2006-09-28
AU2003220808A1 (en) 2004-10-25
KR20050110700A (en) 2005-11-23

Similar Documents

Publication Publication Date Title
USRE45404E1 (en) Powder medicine applicator for nasal cavity
US7353823B2 (en) Powder chemical feeding device for nasal cavity
FI92978B (en) An inhaler for dispensing a drug into a capsule in the form of a pre-dosed powder
KR0177354B1 (en) Powder inhalation medication
EP1671667A1 (en) Powdery medicine dispensing device for nasal cavity
BG65349B1 (en) Powdered drug aerozolizing device and method for using it
EP3682922B1 (en) Medicine storage cartridge with nozzle, sprayer therefor, and powdered medicine dispensing device for nasal cavity
JP3975327B2 (en) Nasal powder medicine administration device
KR101745445B1 (en) Pressurizing type drug injection system
TWI286944B (en) A device for applying medicine powder to nose
RU2324502C2 (en) Medical instrument for administration of powder therapeutical agent into nasal cavity
JP2004129823A (en) Powdery medicine dispensing device for nasal cavity
CN219440286U (en) Inhaler and protective device
CZ20004499A3 (en) Device for atomizing dry powder and method of use thereof

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 8

CC Certificate of correction
FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY